Vasovist Endoleak Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00483665|
Recruitment Status : Completed
First Posted : June 7, 2007
Last Update Posted : November 19, 2008
|Condition or disease||Intervention/treatment|
|Abdominal Aortic Aneurysm||Procedure: Computed tomography angiography Procedure: Magnetic resonance imaging|
After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with computed tomographic (CT) angiography yearly after Endovascular Aneurysm Repair (EVAR).
The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks.
The advantages of magnetic resonance imaging with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Detection of Endoleak by Vasovist-Enhanced Magnetic Resonance Imaging|
|Study Start Date :||June 2006|
Procedure: Computed tomography angiography
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00483665
|Utrecht, Netherlands, 3584 CX|
|Principal Investigator:||Mathias Prokop, MD PhD||UMC Utrecht|